JAYDA RUPP: Open Payments
NPI 1063892677 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 84 payments from 15 companies in 2025. Trend: 2023 $1,508 · 2024 $1,326 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $405 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $244 |
| Janssen Biotech, Inc. | 10 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $194 |
| QOL Medical, LLC | 4 | $97 |
| Madrigal Pharmaceuticals | 6 | $94 |
| Lilly USA, LLC | 2 | $57 |
| Celltrion USA Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, SKYRIZI, Sucraid, REZDIFFRA, RINVOQ, CREON.
Industry payments across KS — which companies pay providers there.
